PAHC vs SO · P/E 13, rev $1.52B vs P/E 22, rev $29.55B
Phibro Animal Health Corporation (PAHC) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
PAHC currently screens at market cap $1.25B and trailing P/E 13.2. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the PAHC and SO stock pages for the full models.
Not investment advice.